Chronic Granulomatous Disease (CGD) is a rare, inherited immunodeficiency caused by mutations in one or more components of the NADPH oxidase complex. This defect compromises the ability of phagocytes ...
BOSTON--(BUSINESS WIRE)--Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo treatments capable of precisely and durably engineering the hematopoietic system ...
Ensoma Inc. has obtained IND clearance from the FDA for its lead program EN-374 in X-linked chronic granulomatous disease (X-CGD). A phase I/II trial in both adult and pediatric patients with X-CGD is ...
Ensoma Inc.’s lead program, EN-374, has been granted orphan drug and rare pediatric disease designations by the FDA for the treatment of X-linked chronic granulomatous disease. Ensoma anticipates ...
Chandigarh: A recent clinical case has highlighted that tattoos, though increasingly popular, may sometimes lead to unexpected skin complications, even years after the procedure.A 21-year-old woman ...
Pyogenic granulomas are noncancerous growths that may appear on the skin following skin injury or hormonal changes. Treatment may only be necessary if they bleed or are in sensitive areas. Pyogenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results